1. Home
  2. BXSL vs ROIV Comparison

BXSL vs ROIV Comparison

Compare BXSL & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Secured Lending Fund of Beneficial Interest

BXSL

Blackstone Secured Lending Fund of Beneficial Interest

HOLD

Current Price

$24.39

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$27.78

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXSL
ROIV
Founded
2018
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
20.7B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BXSL
ROIV
Price
$24.39
$27.78
Analyst Decision
Buy
Strong Buy
Analyst Count
9
8
Target Price
$27.31
$27.56
AVG Volume (30 Days)
2.6M
4.6M
Earning Date
05-06-2026
02-06-2026
Dividend Yield
12.66%
N/A
EPS Growth
N/A
N/A
EPS
2.46
N/A
Revenue
N/A
$29,053,000.00
Revenue This Year
$2.05
N/A
Revenue Next Year
N/A
$594.84
P/E Ratio
$9.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.30
$8.73
52 Week High
$33.73
$30.33

Technical Indicators

Market Signals
Indicator
BXSL
ROIV
Relative Strength Index (RSI) 50.60 50.92
Support Level $24.17 $26.94
Resistance Level $24.88 $27.94
Average True Range (ATR) 0.62 0.96
MACD 0.11 -0.36
Stochastic Oscillator 70.57 23.85

Price Performance

Historical Comparison
BXSL
ROIV

About BXSL Blackstone Secured Lending Fund of Beneficial Interest

Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: